Prolonged
            versus
            standard native
            E. coli
            asparaginase therapy in childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma: final results of the EORTC-CLG randomized phase III trial 58951

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Phase Iii ◽

Phase Iii Trial ◽

E Coli ◽

Role of three childhood acute lymphoblastic leukemia-associated SNPs in a pediatric non-Hodgkin lymphoma cohort

Klinische Pädiatrie ◽

10.1055/s-0032-1310487 ◽

2012 ◽

Vol 224 (03) ◽

Author(s):

T Bartram ◽

K Seidemann ◽

B Burkhardt ◽

W Wössmann ◽

M Zimmermann ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

PF177 NATION-WIDE PROSPECTIVE, REAL-TIME MONITORING OF PEGYLATED E.COLI AND ERWINIA ASPARAGINASE THERAPY IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA AND NON-HODGKIN LYMPHOMA IN BELGIUM

HemaSphere ◽

10.1097/01.hs9.0000558924.10894.63 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 41

Author(s):

V. Mondelaers ◽

T. Lammens ◽

L. Dedeken ◽

A. Uyttebroeck ◽

B. Brichard ◽

...

Keyword(s):

Real Time ◽

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Real Time Monitoring ◽

Non Hodgkin Lymphoma ◽

Erwinia Asparaginase

Childhood acute lymphoblastic leukemia-associated risk-lociIKZF1, ARID5BandCEBPEand risk of pediatric non-Hodgkin lymphoma: a report from the Berlin–Frankfurt–Münster Study Group

Leukemia & Lymphoma ◽

10.3109/10428194.2014.933479 ◽

2014 ◽

Vol 56 (3) ◽

pp. 814-816 ◽

Cited By ~ 2

Author(s):

Thies Bartram ◽

Birgit Burkhardt ◽

Wilhelm Wössmann ◽

Kathrin Seidemann ◽

Martin Zimmermann ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Study Group ◽

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG

Leukemia ◽

10.1038/sj.leu.2403689 ◽

2005 ◽

Vol 19 (5) ◽

pp. 721-726 ◽

Cited By ~ 21

Author(s):

J van der Werff ten Bosch ◽

◽

S Suciu ◽

A Thyss ◽

Y Bertrand ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Lymphoblastic Leukemia ◽

Hodgkin's Lymphoma ◽

Phase Iii ◽

Phase Iii Trial ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Continuation Treatment

Population pharmacokinetics of inotuzumab ozogamicin in relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma

Journal of Pharmacokinetics and Pharmacodynamics ◽

10.1007/s10928-018-9614-9 ◽

2019 ◽

Vol 46 (3) ◽

pp. 211-222 ◽

Cited By ~ 4

Author(s):

May Garrett ◽

Ana Ruiz-Garcia ◽

Kourosh Parivar ◽

Brian Hee ◽

Joseph Boni

Keyword(s):

Population Pharmacokinetics ◽

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Inotuzumab Ozogamicin ◽

Acute lymphoblastic leukemia followed by a clonally-unrelated EBV-positive non-Hodgkin lymphoma and a clonally-related myelomonocytic leukemia cutis

Pediatric Blood & Cancer ◽

10.1002/pbc.10466 ◽

2004 ◽

Vol 42 (4) ◽

pp. 343-349 ◽

Cited By ~ 8

Author(s):

Tomasz Szczepa?ski ◽

Gerard A.M. de Vaan ◽

Auke Beishuizen ◽

Jos� Bogman ◽

Mieke W.J.C. Jansen ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Non Hodgkin Lymphoma ◽

Leukemia Cutis ◽

Myelomonocytic Leukemia

O07 Dexamethasone versus methyl-prednisolone for adult acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL) in patients ≤60 yrs old: final results of the EORTC ALL-4 Phase III Trial

Blood Reviews ◽

10.1016/s0268-960x(07)70025-5 ◽

2007 ◽

Vol 21 ◽

pp. S69

Author(s):

B. Labar ◽

S. Suciu ◽

P. Muus ◽

R. Willemze ◽

J.-P. Marie ◽

...

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

Hodgkin Lymphoma ◽

Lymphoblastic Leukaemia ◽

Phase Iii ◽

Phase Iii Trial ◽

Non Hodgkin Lymphoma ◽

Methyl Prednisolone

Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol

Leukemia & Lymphoma ◽

10.1080/10428190701843239 ◽

2008 ◽

Vol 49 (4) ◽

pp. 757-762 ◽

Cited By ~ 9

Author(s):

Akira Kikuchi ◽

Tetsuya Mori ◽

Jun-Ichiro Fujimoto ◽

Masaaki Kumagai ◽

Shosuke Sunami ◽

...

Keyword(s):

B Cell ◽

Hodgkin Lymphoma ◽

Lymphoblastic Leukemia ◽

Study Group ◽

Cancer Study ◽

Non Hodgkin Lymphoma ◽

Cancer Study Group ◽

Cell Acute Lymphoblastic Leukemia

Characterization of EBV-genome negative “null” and “T” cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma

International Journal of Cancer ◽

10.1002/ijc.2910190505 ◽

1977 ◽

Vol 19 (5) ◽

pp. 621-626 ◽

Cited By ~ 419

Author(s):

Ulrich Schneider ◽

Hans-Ulrich Schwenk ◽

Georg Bornkamm

Keyword(s):

T Cell ◽

Hodgkin Lymphoma ◽

Cell Lines ◽

Lymphoblastic Leukemia ◽

Non Hodgkin Lymphoma ◽

T Cell Lines

Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in Non-Hodgkin Lymphoma (NHL) patients – analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO

BMC Cancer ◽

10.1186/1471-2407-9-153 ◽

2009 ◽

Vol 9 (1) ◽

Cited By ~ 14

Author(s):

Rohini Sharma ◽

David Cunningham ◽

Paul Smith ◽

Graham Robertson ◽

Owen Dent ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Phase Iii ◽

Phase Iii Trial ◽